Liver bioengineering: current status and future perspectives
- PMID: 23322990
- PMCID: PMC3531676
- DOI: 10.3748/wjg.v18.i47.6926
Liver bioengineering: current status and future perspectives
Abstract
The present review aims to illustrate the strategies that are being implemented to regenerate or bioengineer livers for clinical purposes. There are two general pathways to liver bioengineering and regeneration. The first consists of creating a supporting scaffold, either synthetically or by decellularization of human or animal organs, and seeding cells on the scaffold, where they will mature either in bioreactors or in vivo. This strategy seems to offer the quickest route to clinical translation, as demonstrated by the development of liver organoids from rodent livers which were repopulated with organ specific cells of animal and/or human origin. Liver bioengineering has potential for transplantation and for toxicity testing during preclinical drug development. The second possibility is to induce liver regeneration of dead or resected tissue by manipulating cell pathways. In fact, it is well known that the liver has peculiar regenerative potential which allows hepatocyte hyperplasia after amputation of liver volume. Infusion of autologous bone marrow cells, which aids in liver regeneration, into patients was shown to be safe and to improve their clinical condition, but the specific cells responsible for liver regeneration have not yet been determined and the underlying mechanisms remain largely unknown. A complete understanding of the cell pathways and dynamics and of the functioning of liver stem cell niche is necessary for the clinical translation of regenerative medicine strategies. As well, it will be crucial to elucidate the mechanisms through which cells interact with the extracellular matrix, and how this latter supports and drives cell fate.
Keywords: Extracellular matrix; Liver; Regenerative medicine; Scaffold; Stem cells; Tissue engineering.
Figures


Similar articles
-
Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.Stem Cells. 2017 Jan;35(1):42-50. doi: 10.1002/stem.2500. Epub 2016 Oct 2. Stem Cells. 2017. PMID: 27641427 Free PMC article. Review.
-
Liver Bioengineering Using Decellularized Whole-Liver Scaffolds.Methods Mol Biol. 2018;1577:293-305. doi: 10.1007/7651_2017_98. Methods Mol Biol. 2018. PMID: 29101678
-
Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.Tissue Eng Part B Rev. 2019 Aug;25(4):259-290. doi: 10.1089/ten.TEB.2018.0325. Tissue Eng Part B Rev. 2019. PMID: 30896342 Free PMC article. Review.
-
Bioengineering of the digestive tract: approaching the clinic.Cytotherapy. 2021 May;23(5):381-389. doi: 10.1016/j.jcyt.2021.02.006. Epub 2021 Apr 8. Cytotherapy. 2021. PMID: 33840629
-
Decellularized scaffolds in regenerative medicine.Oncotarget. 2016 Sep 6;7(36):58671-58683. doi: 10.18632/oncotarget.10945. Oncotarget. 2016. PMID: 27486772 Free PMC article. Review.
Cited by
-
Cloning: A Review on Bioethics, Legal, Jurisprudence and Regenerative Issues in Iran.World J Plast Surg. 2016 Sep;5(3):213-225. World J Plast Surg. 2016. PMID: 27853684 Free PMC article. Review.
-
Hyaluronan coating improves liver engraftment of transplanted human biliary tree stem/progenitor cells.Stem Cell Res Ther. 2017 Mar 20;8(1):68. doi: 10.1186/s13287-017-0492-7. Stem Cell Res Ther. 2017. PMID: 28320463 Free PMC article.
-
Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.Stem Cells Transl Med. 2016 Aug;5(8):1117-25. doi: 10.5966/sctm.2015-0260. Epub 2016 May 31. Stem Cells Transl Med. 2016. PMID: 27245366 Free PMC article. Review.
-
Creation and implantation of acellular rat renal ECM-based scaffolds.Organogenesis. 2015;11(2):58-74. doi: 10.1080/15476278.2015.1072661. Organogenesis. 2015. PMID: 26186418 Free PMC article.
-
Liver Regeneration: Analysis of the Main Relevant Signaling Molecules.Mediators Inflamm. 2017;2017:4256352. doi: 10.1155/2017/4256352. Epub 2017 Aug 30. Mediators Inflamm. 2017. PMID: 28947857 Free PMC article. Review.
References
-
- Baptista PM, Siddiqui MM, Lozier G, Rodriguez SR, Atala A, Soker S. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology. 2011;53:604–617. - PubMed
-
- Wang Y, Cui CB, Yamauchi M, Miguez P, Roach M, Malavarca R, Costello MJ, Cardinale V, Wauthier E, Barbier C, et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology. 2011;53:293–305. - PubMed
-
- Bao J, Shi Y, Sun H, Yin X, Yang R, Li L, Chen X, Bu H. Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats. Cell Transplant. 2011;20:753–766. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials